Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Genesco (GCO) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Genesco (GCO) over the last 16 years, with Q4 2025 value amounting to $27.0 million.

  • Genesco's Cash & Equivalents fell 1948.9% to $27.0 million in Q4 2025 from the same period last year, while for Nov 2025 it was $27.0 million, marking a year-over-year decrease of 1948.9%. This contributed to the annual value of $34.0 million for FY2025, which is 326.55% down from last year.
  • According to the latest figures from Q4 2025, Genesco's Cash & Equivalents is $27.0 million, which was down 1948.9% from $41.0 million recorded in Q3 2025.
  • Over the past 5 years, Genesco's Cash & Equivalents peaked at $320.5 million during Q1 2022, and registered a low of $19.2 million during Q2 2024.
  • Its 5-year average for Cash & Equivalents is $102.7 million, with a median of $39.2 million in 2023.
  • In the last 5 years, Genesco's Cash & Equivalents soared by 16418.11% in 2021 and then tumbled by 8864.32% in 2022.
  • Genesco's Cash & Equivalents (Quarter) stood at $282.8 million in 2021, then crashed by 88.64% to $32.1 million in 2022, then tumbled by 32.45% to $21.7 million in 2023, then soared by 54.8% to $33.6 million in 2024, then decreased by 19.49% to $27.0 million in 2025.
  • Its Cash & Equivalents stands at $27.0 million for Q4 2025, versus $41.0 million for Q3 2025 and $21.7 million for Q2 2025.